Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2010 - 2022)
Catalyst Pharmaceuticals (CPRX) posted Other Non-Current Assets of $9000.0 for Q4 2022, little changed on a QoQ basis from $9000.0 in Q3 2022, and little changed year-over-year from $9000.0 in Q4 2021.
Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2010 - 2022) Analysis & Trends
Catalyst Pharmaceuticals' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $9000.0 for Q4 2022.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $9000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $9000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $9000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $9000.0 for Q4 2022 at Catalyst Pharmaceuticals, roughly flat from $9000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $9000.0 in Q4 2020 and bottomed at $8888.0 in Q1 2018.
- A 5-year average of $8938.4 and a median of $8888.0 in 2018 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2018 — Other Non-Current Assets changed 0.0% — and 2020, when it rose 1.26%.
- Catalyst Pharmaceuticals' Other Non-Current Assets stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then increased by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
- Business Quant data shows CPRX's Other Non-Current Assets at $9000.0 in Q4 2022, $9000.0 in Q3 2022, and $9000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 8,888.00 |
| Jun 30, 2020 | 8,888.00 |
| Mar 31, 2020 | 8,888.00 |
| Dec 31, 2019 | 8,888.00 |
| Sep 30, 2019 | 8,888.00 |
| Jun 30, 2019 | 8,888.00 |
| Mar 31, 2019 | 8,888.00 |
| Dec 31, 2018 | 8,888.00 |
| Sep 30, 2018 | 8,888.00 |
| Jun 30, 2018 | 8,888.00 |
| Mar 31, 2018 | 8,888.00 |